TTRX
NASDAQ · Pharmaceuticals
Turn Therapeutics Inc
$5.99
+0.22 (+3.81%)
Open$5.71
Previous Close$5.77
Day High$5.99
Day Low$5.56
52W High$26.50
52W Low$2.57
Volume—
Avg Volume44.7K
Market Cap174.86M
P/E Ratio—
EPS$-0.13
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 28.41M | 28.26M | 24.54M |
| Net Income | 5.07M | 4.33M | 4.07M |
| Profit Margin | 17.8% | 15.3% | 16.6% |
| EBITDA | 7.12M | 6.76M | 5.89M |
| Free Cash Flow | 5.68M | 5.26M | 4.99M |
| Rev Growth | +18.7% | -2.9% | -7.4% |
| Debt/Equity | 0.72 | 0.77 | 0.81 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |